Pharmacokinetic interaction of riociguat with ketoconazole, clarithromycin, and midazolam
about
Assessment of the effects of hepatic impairment and smoking on the pharmacokinetics of a single oral dose of the soluble guanylate cyclase stimulator riociguat (BAY 63-2521)Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients.Clinical Pharmacokinetic and Pharmacodynamic Profile of Riociguat.
P2860
Pharmacokinetic interaction of riociguat with ketoconazole, clarithromycin, and midazolam
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Pharmacokinetic interaction of riociguat with ketoconazole, clarithromycin, and midazolam
@en
type
label
Pharmacokinetic interaction of riociguat with ketoconazole, clarithromycin, and midazolam
@en
prefLabel
Pharmacokinetic interaction of riociguat with ketoconazole, clarithromycin, and midazolam
@en
P2093
P2860
P356
P1476
Pharmacokinetic interaction of riociguat with ketoconazole, clarithromycin, and midazolam
@en
P2093
Corina Becker
Dirk Thomas
Erich R Arens
Gerrit Weimann
Hartmut Dietrich
Michael Reber
Reiner Frey
Sigrun Unger
Wolfgang Mück
P2860
P304
P356
10.1086/685016
P433
P577
2016-03-01T00:00:00Z